Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Relevance and Factors Predicting for Early Lymphocyte Recovery After Allogeneic Bone Marrow Stem Cell Transplantation (BMT).

Ulas D. Bayraktar, MD, Rima M Saliba, PhD, Gabriela Rondon, MD, Antonio Di Stasi, MD, Partow Kebriaei, M.D., Marcos de Lima, MD, Richard E. Champlin, Stefan O. Ciurea

Blood (2012) 120 (21): 3053.

https://doi.org/10.1182/blood.V120.21.3053.3053

Published: 2012

Journal Articles

Chromosome 7 Abnormalities in Allogeneic Transplantation for AML and MDS

Vamsi Kota, MBBS, Rima M. Saliba, PhD, Ulas D. Bayraktar, MD, Amer Beitinjaneh, MD, Julianne J Chen, Simrit Parmar, M.D., Sergio A Giralt, MD, Gabriela Rondon, MD, Stefan O Ciurea, MD, Partow Kebriaei, MD, Muzaffar H Qazilbash, MD, Borje S Andersson, MD, PhD, Richard Champlin, MD, Marcos De Lima, MD

Blood (2011) 118 (21): 2037.

https://doi.org/10.1182/blood.V118.21.2037.2037

Published: 2011

Journal Articles

Improved Early Outcomes with T-Cell Replete (TCR) Compared with T-Cell Depleted (TCD) Haploidentical Stem Cell Transplantation (HaploSCT)

Stefan O Ciurea, MD, Rima M. Saliba, PhD, Ulas D. Bayraktar, MD, Susan Xie, Gabriela Rondon, MD, Simrit Parmar, M.D., Partow Kebriaei, MD, Nivia Montes, PA, Manish Sharma, MD, Marina Konopleva, M.D., Ph.D., Yago Nieto, MD, PhD, Muzaffar H. Qazilbash, MD, Amin M Alousi, MD, Borje S Andersson, MD, PhD, Chitra M Hosing, MD, Elizabeth J Shpall, MD, Issa F. Khouri, MD, Marcos de Lima, MD, Richard Champlin, MD

Blood (2011) 118 (21): 320.

https://doi.org/10.1182/blood.V118.21.320.320

Published: 2011

Journal Articles

Ex-Vivo T Cell-Depleted Versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission: A Comparison of Outcomes in Two Institutions

Ulas D. Bayraktar, MD, Marcos De Lima, MD, Saliba M Rima, MD, Molly Maloy, Hugo Castro-Malaspina, MD, Julianne J Chen, Gabriela Rondon, MD, Alexandre Chiattone, MD, Ann A. Jakubowski, MD, PhD, Farid Boulad, MD, Nancy A. Kernan, MD, Richard J. O'Reilly, MD, Richard Champlin, MD, Sergio A Giralt, MD, Borje S Andersson, MD, PhD, Esperanza B Papadopoulos, MD

Blood (2011) 118 (21): 2013.

https://doi.org/10.1182/blood.V118.21.2013.2013

Published: 2011

Journal Articles

Hematopoietic Cell Transplantation – Specific Comorbidity Index As An Instrument to Predict Survival in Patients Admitted to Intensive Care Unit Early After Allogeneic Transplantation

Ulas D. Bayraktar, MD, Elizabeth J Shpall, MD, Ping Liu, MS, Stefan O Ciurea, MD, Marcos De Lima, MD, Gabriela Rondon, MD, Kristen J Price, M.D., Richard Champlin, MD, Joseph L Nates, M.D.

Blood (2011) 118 (21): 147.

https://doi.org/10.1182/blood.V118.21.147.147

Published: 2011

Journal Articles

High-Dose Methotrexate and Azidothymidine in Combination with Alternating DA-EPOCH Is An Effective Regimen for the Treatment of EBV-Related Plasmablastic Lymphoma.

Ulas D Bayraktar, Roberto Ochoa, MD, Soley Bayraktar, MD, Maria Matsangou, Juan Carlos Ramos, MD

Blood (2009) 114 (22): 4753.

https://doi.org/10.1182/blood.V114.22.4753.4753

Published: 2009

Journal Articles

An Unusual Presentation of Acute Biphenotypic Leukemia without Bone Marrow Involvement

Ulas D Bayraktar, Maricer Escalon, MD

Blood (2008) 112 (11): 3995.

https://doi.org/10.1182/blood.V112.11.3995.3995

Published: 2008

NARROW

Relevance and Factors Predicting for Early Lymphocyte Recovery After Allogeneic Bone Marrow Stem Cell Transplantation (BMT).

Chromosome 7 Abnormalities in Allogeneic Transplantation for AML and MDS

Improved Early Outcomes with T-Cell Replete (TCR) Compared with T-Cell Depleted (TCD) Haploidentical Stem Cell Transplantation (HaploSCT)

Ex-Vivo T Cell-Depleted Versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission: A Comparison of Outcomes in Two Institutions

Hematopoietic Cell Transplantation – Specific Comorbidity Index As An Instrument to Predict Survival in Patients Admitted to Intensive Care Unit Early After Allogeneic Transplantation

High-Dose Methotrexate and Azidothymidine in Combination with Alternating DA-EPOCH Is An Effective Regimen for the Treatment of EBV-Related Plasmablastic Lymphoma.

An Unusual Presentation of Acute Biphenotypic Leukemia without Bone Marrow Involvement

Email alerts

ASH Publications

American Society of Hematology

Relevance and Factors Predicting for Early Lymphocyte Recovery After Allogeneic Bone Marrow Stem Cell Transplantation (BMT).

Chromosome 7 Abnormalities in Allogeneic Transplantation for AML and MDS

Improved Early Outcomes with T-Cell Replete (TCR) Compared with T-Cell Depleted (TCD) Haploidentical Stem Cell Transplantation (HaploSCT)

Ex-Vivo T Cell-Depleted Versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission: A Comparison of Outcomes in Two Institutions

Hematopoietic Cell Transplantation – Specific Comorbidity Index As An Instrument to Predict Survival in Patients Admitted to Intensive Care Unit Early After Allogeneic Transplantation

High-Dose Methotrexate and Azidothymidine in Combination with Alternating DA-EPOCH Is An Effective Regimen for the Treatment of EBV-Related Plasmablastic Lymphoma.

An Unusual Presentation of Acute Biphenotypic Leukemia without Bone Marrow Involvement

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only